19th ISAM Annual Conference
Addiction Medicine: New Frontier

26-29 October, 2017 Abu Dhabi,UAE

Plenary Speakers


View Profile
X

H.E. Hamad Al Ghaferi

H.E. Hamad is the Director General of the National Rehabilitation Centre, Abu Dhabi, UAE Since September 2008. He receives his Bachelor of Medicine, Bachelor of Surgery (MBBS) from Faculty of Medicine, Jordan University of Science and Technology, Irbid, Kingdom Hashemite of Jordan, June 1999. He had his Master of Public Health (MPH)

H.E. Hamad Al Ghaferi

MBBS, MPH, PhD
Conference President
Director General NRC


View Profile
X

Ahmed Okasha

Ahmed Okasha

Past Presiden WPA
Director of WHO Collaborating Center for
Training & Research
Founder & Emeritus Professor - Ain Shams University


View Profile
X

Vladimir Poznyak

Vladimir Poznyak

MBBS, MPH, MD
Coordinator, Management of
Substance Abuse
World Health Organization


View Profile
X

Thomas McLellan

Dr. McLellan has been a career researcher for 35 years at the Treatment Research Institute (which he founded in 1992) and Professor of Psychiatry at the University of Pennsylvania.
In his career he has published over 450 research articles and successfully completed over 150 NIH research grants. He has received Life Achievement Awards from the American, Swedish, Italian and British Societies of Addiction Medicine.
From 2009 - 2012 Dr. McLellan was unanimously confirmed by the US Senate as Deputy Director of the White House Office of National Drug Control Policy, where he was the principal author of President Obama's National Drug Control Strategy. In 2016 Dr. McLellan served as Senior Editor for the US Surgeon General report on Facing Addiction.
Dr. McLellan holds a B.A. from Colgate University and a Ph.D. from Bryn Mawr College. He received postgraduate training in psychology at Oxford University in England.

Thomas McLellan

PhD
Chairman of the Board
Treatment Research Institute


View Profile
X

Rafia Ghubash

Prof. RafiaGhubash is the first qualified psychiatrist in the UAE . She had a successful career in psychiatry including the accomplishment of conducting pioneering epidemiological research on the sociocultural risk factors for psychiatric disorders in the UAE community and attained the PhD at University of London. She conducted other studies in applied mental health research and published 45 papers in international peer-reviewed journals.

Notwithstanding her successful career in academic psychiatry, open for her the opportunity to take up leadership positions in medical education as Dean of the Faculty of Medicine and Health Sciences at UAE University 1992-2000 and rapidly progressing to become the first woman President of the Arabian Gulf University 2001-2009. She successfully completed eight years as President with many achievements including innovations in medical education.

She then grew out of psychiatry enriched with the vision and mission towards better mental health for all: from person centred to people centred approaches to more positive mental health.

She concludes with the notion that humans are more whole and complete when they become better routed, more true to and harmonious with their culture, values and traditions and experience less alienation and better mental health.

On the 100th anniversary of International Women's Day (8 March 2011), Women Deliver organization announce that Prof. Rafia Obaid Ghubash have been chosen as one of the "The most inspiring individuals delivering for women" among Women Deliver 100. Prof. Rafia's many and varied educational, social and intellectual contributions to national, regional and international organizations is reflected in her membership of professional associations and civic organizations, such as:
Board of Trustees Dubai Cutlure, (2014 - current)
Board of Trustees Emirates airline festival of Literature, (2014 - current)
Board of trustees in The Khalaf Ahmad Al Habtoor Foundation, (2014 -current)
Councilor membership of the World Future Council in Germany (2003 -current) Membership of the Advisory Council for UNDP, (2003 -current) Board of Trustees for the Sheikh KhalifaEducational Awards in UAE, (2009 - 2013) WHO's Scientific Committees (2008-2001)
Her many honors and awards include:
The Rashid Awards for Distinguished Scientist (1988 and 1992), Al-Owais Research Award (1992, 1994 and 1995), Award of Distinction for Citizens from Umalmomenien Women Association (2002), Sheikh Hamden bin Rashid Award for Medical Sciences (2003/ 2004). TaryamOmranJouranilsm Awards 2012 Arab Women Award; Education 2012 Sheikh Mohammed bin Rashid Al Maktoum Patron of Arts Award 2013 Cultural Personality of the Year in Al Owais Creative Award, 2014

Rafia Ghubash

MD
Professor of Psychiatry
UAE University


View Profile
X

Susumu Higuchi

Susumu Higuchi

MD, PhD
Director, National Hospital Organization
Kurihama Medical and Addiction Center

 

View Profile
X

Sir John Strang

Sir John Strang

MD
Head of Addiction Department
King's College London

 

View Profile
X

Keith Humphreys

Professor & Section Director for Mental Health Policy, Department of Psychiatry & Behavioral Sciences, Stanford University. Senior Research Career Scientist, VA Health Services Research Center, Palo Alta. Honorary Professor of Psychiatry, Institute of Psychiatry, Kings College London

Keith Humphreys

MD
Professor & Section Director
for Mental Health Policy
Stanford University

 

View Profile
X

Kathleen T. Brady

Distinguished University Professor
Vice President for Research
Medical University of South Carolina
Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 30 years. Her research focuses on pharmacotherapy of substance use disorders, comorbidity of psychiatric disorders and addictions (e.g., posttraumatic stress disorder and bipolar disorder), gender differences and women's issues in addictions, and the neurobiologic connections between stress and addictions. She has received numerous federal research grants and has published over 300 peer-reviewed journal articles and co-edited 10 books. She is the principal Investigator of MUSC's Clinical and Translational Science Award (CTSA), Principal Investigator of the Southern Consortium Node of the NIDA-funded Clinical Trials Network and Director of MUSC's Women's Research Center. Her dedication to furthering research careers has attracted a number of junior investigators and clinicians. She has mentored over 25 individual NIH funded faculty development awards (K-awards) and is presently involved in three institutional faculty development programs (CTSA KL2; BIRCWH, NIDA K-12). She has been the Co-Director of MUSC's IDA NIH- funded post-doctoral fellowship program focused on translational research training in addictions for 15 years.

Kathleen T. Brady

MD, PhD
Distinguished University Professor
Medical University of
South Carolina

 

View Profile
X

Marilyn Huestis

Marilyn Huestis

MD
Adjunct Professor
University of Maryland
School of Medicine

 

View Profile
X

Norman Wetterau

Dr. Norman Wetterau represented ISAM and ASAM at UNGASS 2016. He is a clinical Associate Professor of Family Medicine at the University of Rochester School of Medicine, was visiting professor for Mental Health and Addiction at Hope Africa Medical School, Burundi for 6 years and is an Adjutant Professor at Northeastern Seminary in the Masters program on Theology and Social Justice. He practices family and addiction medicine in upstate New York. He is a previous board member of ASAM.

Norman Wetterau

MD
Clinical Associate Professor of Family Medicine
University of Rochester
School of Medicine

 

View Profile
X

Dr. Ivan Montoya

M.P.H., M.D.
Acting Director of the Division of Therapeutics
and Medical Consequences of NIDA.

Dr. Montoya is the Acting Director of the Division of Therapeutics and Medical Consequences (DTMC) of the National Institute on Drug Abuse (NIDA). He received his M.D. from the University of Antioquia (Colombia), completed residency training in Psychiatry at the University of Antioquia and the University of Maryland Hospital (Baltimore), and a Master of Public Health at The Johns Hopkins School of Public Health. He was a Fulbright Fellow at The Johns Hopkins School of Public Health, Visiting Foreign Fellow at the Intramural Research Program of NIDA, Consultant for the Pan American Health Organization, and Director of the Practice Research Network of the American Psychiatric Association. He has published extensively in the areas of etiology, prevention, treatment (pharmacological and non-pharmacological), and medical consequences of drug abuse. He recently was the editor of a book summarizing the science on biologics (vaccines, monoclonal antibodies, and enzymes) to treat substance use disorders.

Dr. Ivan Montoya

M.P.H., M.D.
Acting Director of the Division of Therapeutics
and Medical Consequences of NIDA.

 

View Profile
X

Desiree A. Bruce-Lyle

Desiree A. Bruce-Lyle

Judge
Superior Court of San Diego County
California

Destination & Cultural Partner

Co Sponsors

Platinum Sponsors



Silver Sponsor



Bronze Sponsor



Supporting Associations


Main Media Partner



Media Partners